FindTrial
Sign In

Interventional treatment of ventricular septal defect with tricuspid regurgitation

Interventional treatment of ventricular septal defect with tricuspid regurgitation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ONB-15007639
Enrollment
Unknown
Registered
2015-12-25
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventricular septal defect

Interventions

interventional group:Percutaneous interventional occlusion
operation group:ventricular septal defect occlusion

Sponsors

Wuhan Asia Heart Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) the regurgitation caused by the blood flow through the chest heart or the chordae tendineae of tricuspid valve directly. (2) in accordance with the standards of ventricular septal defect. The age is more than 3 years cold, and weight is greater than 10Kg (3)Patients voluntarily accepted interventional therapy and willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Tricuspid regurgitation was caused by other reasons or tricuspid valve had organic lesions; (2) ventricular septal defect interventional surgery was failed and changed to open chest operation (3) the follow-up period was less than six months

Design outcomes

Primary

MeasureTime frame
heart rate;Left heart diameter;The position of occluder;—

Countries

China

Contacts

Public ContactZhang Gangcheng
yxsxs2015@163.com18963980946

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026